- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 1.03M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 984.67K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 138.5K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $18.99K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.59M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.18M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $3.68M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $5.16M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $4.18M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $5.98M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $3.87M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $5.73M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.41M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.12M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.42M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.14M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.97M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.46M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5.6M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $7.12M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.95 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$13.46 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.95 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$13.46 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $811.84K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $784.8K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.92M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.86M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.94M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.89M |